COVID vaccine: some waste is normal – but here's how it is being kept to a minimum

With reports emerging of vaccine wastage across the world, medical supply chain experts explain why that's to be expected.

Liz Breen, Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford • conversation
Jan. 11, 2021 • ~8 min

Delaying second COVID-19 vaccine doses will make supplies last longer but comes with risks

With vaccine shortages looming, experts are debating whether it is important to receive two doses or whether it's better to give one dose to more people and give a second when the supply is better.

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
Jan. 11, 2021 • ~11 min

Should pregnant women get the COVID-19 vaccine? Will it protect against asymptomatic infections and mutated viruses? An immunologist answers 3 questions

With vaccines forthcoming for most Americans, many groups, including expectant mothers, are wondering if the vaccine is safe for them and their babies. A physician-scientist explains.

William Petri, Professor of Medicine, University of Virginia • conversation
Dec. 23, 2020 • ~6 min

Why it matters that the coronavirus is changing – and what this means for vaccine effectiveness

A new strain of the SARS-CoV-2 virus that causes COVID-19 appears to be spreading fast in the the UK. What does this mean for vaccine developers and vaccinations?

David Kennedy, Assistant Professor of Biology, Penn State • conversation
Dec. 22, 2020 • ~6 min

The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 – and then developing multiple vaccines

The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.

David Pride, Associate Director of Microbiology, University of California San Diego • conversation
Dec. 17, 2020 • ~11 min

Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's and doesn't require supercold temperature

There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
Nov. 24, 2020 • ~9 min

COVID-19 vaccines were developed in record time – but are these game-changers safe?

Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.

William Petri, Professor of Medicine, University of Virginia • conversation
Nov. 20, 2020 • ~6 min

/

1